Skip to main content
. 2008 Apr 28;76(7):3281–3292. doi: 10.1128/IAI.01646-07

TABLE 2.

List of primers and probes used in this work

Gene or probe Forward primer Reverse primer Size (bp) Reference or origina
Genes
    aggR 5′-GTATGAAATTAAAACAA ACATCG-3′ 5′-GTTTATTGGCTTTTAAAATAG TC-3′ 800 This study
    aggA 5′-AAATATGAGAAGAAAGAA-3′ 5′-AAAAATTAATTCCGGTATGG-3′ 500 This study
    aafA 5′-CAGAATGTTTGCGATTGCTAC-3′ 5′-TTTGTCACAAGCTCAGCATT-3′ 468 This study
    agg3A 5′-GTATCATTGCGAGTCTGGTAT TCAG-3′ 5′-GGGCTGTTATAGAGTAACTTCC AG-3′ 462 5
    hdaA 5′-TCCATTATGTCAGGCTGCAA-3′ 5′-GGCGTTAACGTCTGATTTCC-3′ 411 This study
    hdaABCD 5′-TCGCTGGGAAAGTTA AAT GG-3′ 5′-TTTGCTGTGGTTTTTGTTG-3′ 3,498 This study
    aggC 5′-GTGATCCCCCAAGCTACAGA-3′ 5′-ATCCCAATGCATTACCCTGA-3′ 850 This study
    aafC 5′-AACGGATACGCCAAGTGTTC-3′ 5′-GCACCTGTGGTGAGAGGAAT-3′ 496 This study
    agg3C 5′-GTT TGGAAC CGGGAA TTA ACA TTG-3′ 5′-ATACTTTAGATACCC CTC ACG CAG-3′ 485 5
    hdaC 5′-GGGGGAGGGAATAGATATGG-3′ 5′-CTCATCAGAGCCCACACTCA-3′ 700 This study
    aaiC 5′-ATTGTCCTCAGGCATTTCAC-3′ 5′-ACGACAACCCCTGATAAACAA-3′ 215 CVD collection
    pet 5′-ACTGGCGGACTCATTGCTGT-3′ 5′-GCGTTTTTCCGTTCCCTATT-3′ 800 CVD collection
    setA 5′-CCCTGATATTCCAGGGACAT-3′ 5′-ATGGAAGTCAGCGTCTTTCA-3′ 134 4
    astA 5′-ATGCCATCAACACAGTATAT-3′ 5′-GCGAGTGACGGCTTTGTAGT-3′ 110 CVD collection
    aap 5′-ATGAAAAAAATTAA GTTTGTTATCTT-3′ 5′-TTATTTAACCCATTCG GTTAGAGC-3′ 356 56
    cat 5′-CTGGATATACCACCGTTG ATATA-3′ 5′-GGGTGAACACTATCCCATAT-3′ 100 4
    cdtABC 5′-AATTGTAAATCCTTTGGGGCG TTC-3′ 5′-GATCTAGGGTGCAAGGGGCT ATT-3′ 2,009 This study
    aafCI 5′-TCTGACGGCGTGTAGTTCTCA CCCA-3′ This study
    aafCIV 5′-GTCTATAGGGCAAGACAGCG TGAAG-3′ This study
    agg3CII 5′-CATCACCCCCTAAAAGGGAC ACTG-3′ This study
    agg3CIII 5′-AGGCCCGAACTCATGCACGTT AT-3′ This study
Probes
    AAF/I 5′-AAATATGAGAAGAAAGAA-3′ 5′-AAAAATTAATTCCGGTATGG-3′ This study
    AAF/II 5′-CAGAATGTTTGCGATTGCTAC-3′ 5′-TTTGTCACAAGCTCAGCATT-3′ This study
    AAF/III 5′-GTATCATTGCGAGTCTGGTAT TCAG-3′ 5′-GGGCTGTTATAGAGTAACTTCC AG-3′ This study
a

CVD, Center for Vaccine Development.